Fintel reports that on September 28, 2023, RBC Capital reiterated coverage of Encompass Health (NYSE:EHC) with a Outperform recommendation.
Analyst Price Forecast Suggests 20.76% Upside
As of August 31, 2023, the average one-year price target for Encompass Health is 81.60. The forecasts range from a low of 71.71 to a high of $89.25. The average price target represents an increase of 20.76% from its latest reported closing price of 67.57.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Encompass Health is 4,719MM, an increase of 3.16%. The projected annual non-GAAP EPS is 3.29.
What is the Fund Sentiment?
There are 898 funds or institutions reporting positions in Encompass Health. This is a decrease of 7 owner(s) or 0.77% in the last quarter. Average portfolio weight of all funds dedicated to EHC is 0.33%, an increase of 12.58%. Total shares owned by institutions increased in the last three months by 0.40% to 112,142K shares. 
The put/call ratio of EHC is 0.46, indicating a bullish outlook.
What are Other Shareholders Doing?
Wellington Management Group Llp holds 8,992K shares representing 8.97% ownership of the company. In it's prior filing, the firm reported owning 9,182K shares, representing a decrease of 2.11%. The firm increased its portfolio allocation in EHC by 16.97% over the last quarter.
William Blair Investment Management holds 5,334K shares representing 5.32% ownership of the company. In it's prior filing, the firm reported owning 5,308K shares, representing an increase of 0.49%. The firm increased its portfolio allocation in EHC by 15.75% over the last quarter.
Invesco holds 3,250K shares representing 3.24% ownership of the company. In it's prior filing, the firm reported owning 2,360K shares, representing an increase of 27.38%. The firm increased its portfolio allocation in EHC by 1,649.74% over the last quarter.
Jpmorgan Chase holds 3,096K shares representing 3.09% ownership of the company. In it's prior filing, the firm reported owning 3,144K shares, representing a decrease of 1.56%. The firm increased its portfolio allocation in EHC by 775.43% over the last quarter.
IJH - iShares Core S&P Mid-Cap ETF holds 3,041K shares representing 3.03% ownership of the company. In it's prior filing, the firm reported owning 3,079K shares, representing a decrease of 1.25%. The firm increased its portfolio allocation in EHC by 18.41% over the last quarter.
Encompass Health Background Information
(This description is provided by the company.)
As a national leader in integrated healthcare services, Encompass Health offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. With a national footprint that includes 137 hospitals, 241 home health locations, and 82 hospice locations in 39 states and Puerto Rico, the Company provides high-quality, cost-effective integrated healthcare. Encompass Health is ranked as one of Fortune's 100 Best Companies to Work For.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
